Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on April 30, 2025
OpenAna launches First Agentic Autonomous Engineer Transforming DevOps, SRE, and Cloud Operations
EIN Presswire
·
April 30, 2025
OpenAna introduces the first Autonomous Engineer for end-to-end DevOps, SRE, and cloud reliability beyond AI assistants and manual toil. NEW YORK, NY, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- As enterprises demand greater reliability, faster …
Aveta Biomics Announces Abstract Acceptance for Presentation at the 2025 ASCO Annual Meeting
EIN Presswire
·
April 30, 2025
Aveta Biomics to present the results from Phase 2A trial of APG-157 as neoadjuvant monotherapy for head and neck cancer at ASCO 2025. BEDFORD, MA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Aveta Biomics, a clinical-stage biotechnology company …
Xeomics Joins JumpStart to Accelerate AI in Healthcare and Precision Medicine
EIN Presswire
·
April 30, 2025
Collaboration underscores Xeomics's ongoing commitment to the adoption of precision medicine solutions in the US BOSTON, MA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Xeomics, a precision medicine startup today announced a strategic …
Healthcare's Digital Future: CurbCutOS Champions Accessibility Ahead of The EAA Deadline
EIN Presswire
·
April 30, 2025
Empowering Healthcare, One Click at a Time BOISE, ID, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- The European Accessibility Act (EAA) deadline looms large on June 28, 2025, urging healthcare organizations to make accessibility a priority. …
Captive Resources Launches 'Captivating Health Insights' Podcast to Equip Employers with Innovative Healthcare Solutions
EIN Presswire
·
April 30, 2025
A new podcast from Captive Resources shares expert insights and practical strategies to help employers control healthcare costs and improve workforce well-being ITASCA, IL, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Captive Resources’ Health …
GenBio's Chief Science Officer Professor Lindsay Brown Investigates the Microbiome-Gut-Brain Axis
EIN Presswire
·
April 30, 2025
"All disease begins in the gut." Hippocrates ALISO VIEJO, CA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- GenBio’s Chief Scientific Officer is internationally recognized for investigating the health impact of chronic diseases of Australian …
.med URLs coming soon to the Internet
EIN Presswire
·
April 30, 2025
Pre-registration starts in May, 2025 CLEVELAND, OH, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Medistry LLC, the global internet Registry Operator of the .med Top Level Domain (TLD), is making .med URLs available as early as May of this year. …
Psychotherapist Explores Connection Between Spirituality and Mental Health in Writings Available on Website
EIN Presswire
·
April 30, 2025
LOS ANGELES, CA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- May marks Mental Health Awareness Month, a topic near and dear to the late Dr. Pieter Noomen, a psychotherapist who worked in suicide prevention and hospice and served as a senior …
Findability Sciences Deepens Global AI Footprint with Strategic Multi-Million Dollar Expansion in Mumbai, India
EIN Presswire
·
April 30, 2025
New Mumbai Hub and Innovation …
Revival Research Institute Aligns Strategy and Support at Upcoming All-Hands Meeting, May 2025
EIN Presswire
·
April 30, 2025
SOUTHFIELD, MI, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Revival Research Institute is proud to announce its upcoming 𝐀𝐥𝐥-𝐇𝐚𝐧𝐝𝐬 𝐌𝐞𝐞𝐭𝐢𝐧𝐠, set to take place on 𝐌𝐚𝐲 𝟐, 𝟐𝟎𝟐𝟓 Themed “Digitally Driven, Process Powered: The Future of Clinical …
Jane Partners with Whereby to Deliver Secure and Reliable Virtual Healthcare Appointments
EIN Presswire
·
April 30, 2025
Whereby, a leading video conferencing provider, is proud to announce its partnership with Jane.app VANCOUVER, CANADA, April 30, 2025 /EINPresswire.com/ -- Whereby, a leading video conferencing provider, is proud to announce its partnership with Jane.app …
Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia
GlobeNewswire
·
April 30, 2025
NBI-1117568 is an oral, muscarinic M4 selective receptor agonist discovered by Nxera advancing through clinical development under a multi-program collaboration with Neurocrine For more information, please read Neurocrine’s announcement (link) Tokyo, Japan …
Therasage Announces TheraVibe™: A New Advancement in Wearable Wellness Technology
EIN Presswire
·
April 30, 2025
herasage unveils TheraVibe™, a new line of wearable frequency-infused patches designed to support natural energy, recovery, and vitality. CALIFORNIA, CA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Therasage, a leading innovator in natural …
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
GlobeNewswire
·
April 30, 2025
Amicus licenses exclusive U.S. rights to commercialize DMX-200 for the treatment of Focal Segmental Glomerulosclerosis (FSGS) DMX-200 is in a pivotal Phase 3 trial for FSGS, a rare and fatal kidney disease with no FDA-approved therapies Dimerix …
Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations
GlobeNewswire
·
April 30, 2025
Tokyo, Japan and Cambridge, UK, 1 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces the appointment of Shinya Tsuzuki, as Head of Investor Relations. Mr. Tsuzuki will lead Nxera’s Investor Relations (IR) team in Japan …
Hidden Strength Releases New Survey on the State of Mental Health for Teenagers
EIN Presswire
·
April 30, 2025
LONDON, UNITED KINGDOM, April 30, 2025 /EINPresswire.com/ -- Hidden Strength, a digital platform and app designed to give free therapy and support the mental wellness of teenagers and young adults, announced the results of its comprehensive survey …
UPDATE – The International Myeloma Foundation Mourns the Loss of Board Member and Longtime Philanthropist John O’Dwyer
GlobeNewswire
·
April 30, 2025
STUDIO CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members and longtime philanthropist John O’Dwyer, who lived with myeloma for 18 …
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
GlobeNewswire
·
April 30, 2025
Cincinnati, OH, April 30, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq”) on April 24, 2025 indicating that the Company’s failure to file …
AdCare Hospital Names New Executive Director to Tackle Growing Addiction Crisis Across Massachusetts
GlobeNewswire
·
April 30, 2025
WORCESTER, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- As Massachusetts continues to see waves of preventable deaths from the opioid overdose epidemic, AdCare Hospital, a longstanding provider of addiction treatment services in Worcester, MA, has named Laura …
New Study Shows Castle Biosciences’ DecisionDx®-Melanoma Test Outperforms Staging and CP-GEP in Identifying Patients at Low Risk of Sentinel Lymph Node Positivity
GlobeNewswire
·
April 30, 2025
Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to forgo sentinel lymph node biopsy (SLNB) surgery …